123 related articles for article (PubMed ID: 1873477)
1. Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis.
Otterness IG; Bliven ML; Downs JT; Natoli EJ; Hanson DC
Cytokine; 1991 Jul; 3(4):277-83. PubMed ID: 1873477
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of tenidap on the zymosan- and lipopolysaccharide-induced expression of mRNA for proinflammatory cytokines in macrophages.
Bondeson J; Sundler R
Biochem Pharmacol; 1996 Jul; 52(1):35-42. PubMed ID: 8678906
[TBL] [Abstract][Full Text] [Related]
5. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
[TBL] [Abstract][Full Text] [Related]
6. Leukotrienes do not regulate interleukin 1 production by activated macrophages.
Parkar BA; McCormick ME; Foster SJ
Biochem Biophys Res Commun; 1990 Jun; 169(2):422-9. PubMed ID: 2357213
[TBL] [Abstract][Full Text] [Related]
7. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response.
Sipe JD; Bartle LM; Loose LD
J Immunol; 1992 Jan; 148(2):480-4. PubMed ID: 1729367
[TBL] [Abstract][Full Text] [Related]
8. Tenidap reduces the level of interleukin 1 receptors and collagenase expression in human arthritic synovial fibroblasts.
Martel-Pelletier J; Mineau F; Tardif G; Fernandes JC; Ranger P; Loose L; Pelletier JP
J Rheumatol; 1996 Jan; 23(1):24-31. PubMed ID: 8838504
[TBL] [Abstract][Full Text] [Related]
9. Tenidap-modulated proinflammatory cytokine activation of a monocyte cell line.
Golding S; Emery P; Young SP
J Immunol; 1995 May; 154(10):5384-90. PubMed ID: 7730639
[TBL] [Abstract][Full Text] [Related]
10. Effects of tenidap on Ca(2+)- and protein kinase C-mediated protein phosphorylation, activation of the arachidonate-mobilizing phospholipase A2 and subsequent eicosanoid formation in macrophages.
Bondeson J; Sundler R
Biochem Pharmacol; 1994 Sep; 48(6):1171-9. PubMed ID: 7945411
[TBL] [Abstract][Full Text] [Related]
11. Modulation of IL-1beta, IL-6, TNF-alpha and PGE(2) by pharmacological agents in explants of membranes from failed total hip replacement.
Lavigne P; Shi Q; Jolicoeur FC; Pelletier JP; Martel-Pelletier J; Fernandes JC
Osteoarthritis Cartilage; 2002 Nov; 10(11):898-904. PubMed ID: 12435335
[TBL] [Abstract][Full Text] [Related]
12. Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
Palacios I; Lopez-Armada MJ; Hernandez P; Sanchez-Pernaute O; Gutierrez S; Miguelez R; Martinez J; Egido J; Herrero-Beaumont G
Clin Exp Immunol; 1998 Mar; 111(3):588-96. PubMed ID: 9528904
[TBL] [Abstract][Full Text] [Related]
13. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
14. Regulation of eicosanoid biosynthesis in the macrophage. Involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors.
Glaser KB; Sung A; Bauer J; Weichman BM
Biochem Pharmacol; 1993 Feb; 45(3):711-21. PubMed ID: 8442770
[TBL] [Abstract][Full Text] [Related]
15. Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1 beta post-translational processing.
Perregaux DG; Svensson L; Gabel CA
J Immunol; 1996 Jul; 157(1):57-64. PubMed ID: 8683156
[TBL] [Abstract][Full Text] [Related]
16. The pharmacologic regulation of interleukin-1 production: the role of prostaglandins.
Otterness IG; Bliven ML; Eskra JD; Reinke M; Hanson DC
Cell Immunol; 1988 Jul; 114(2):385-97. PubMed ID: 2968844
[TBL] [Abstract][Full Text] [Related]
17. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. I. Mechanism and evidence of functional significance.
McNiff P; Svensson L; Pazoles CJ; Gabel CA
J Immunol; 1994 Sep; 153(5):2180-93. PubMed ID: 8051419
[TBL] [Abstract][Full Text] [Related]
18. Effect of tenidap on cartilage integrity in vitro.
Dingle JT; Leeming MR; Martindale JJ
Ann Rheum Dis; 1993 Apr; 52(4):292-9. PubMed ID: 8484696
[TBL] [Abstract][Full Text] [Related]
19. Effects of tenidap and nonsteroidal antiinflammatory drugs on the response of cultured human T cells to interleukin 2 in rheumatoid arthritis.
Hall VC; Wolf RE
J Rheumatol; 1997 Aug; 24(8):1467-70. PubMed ID: 9263136
[TBL] [Abstract][Full Text] [Related]
20. The effects of Tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro.
Mattey DL; Evans E; Dawes PT
Ann Rheum Dis; 1994 Apr; 53(4):250-5. PubMed ID: 8203954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
